Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 4 min 9 sec ago

OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer

Thu, 08/07/2014 - 15:00
BOTHELL, Wash. and VANCOUVER, British Columbia , Aug. 7, 2014 (Healthcare Sales & Marketing Network) -- OncoGenex Pharmaceuticals, Inc. (OGXI) today announced the appointment of John A. Bencich as Vice President and Chief Financial Officer (CFO). John B...
Biopharmaceuticals, Oncology, Personnel
OncoGenex Pharmaceuticals, custirsen, prostate cancer

Cortendo Appoints Matthew Pauls as Chief Executive Officer

Thu, 08/07/2014 - 14:57
GÖTEBORG, Sweden--(Healthcare Sales & Marketing Network)--Cortendo AB (OSE:CORT) announces the appointment of Matthew Pauls as President and Chief Executive Officer effective Monday, August 25, 2014. Mr. Pauls brings to Cortendo more than 20 years ...
Biopharmaceuticals, Endocrinology, Personnel
Cortendo, NormoCort, cortisol, Cushing’s Syndrome

BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes

Wed, 08/06/2014 - 15:20
The only pen needle with patented dual needle shields for enhanced convenience and safety is latest BD innovation for insulin injection FRANKLIN LAKES, N.J., Aug. 6, 2014 -- (Healthcare Sales & Marketing Network) -- BD Medical, a segment of BD (Becton,...
Devices, Drug Delivery, Endocrinology, Product Launch
BD , AutoShield, needle, diabetes

Nodality Expands Senior Leadership Team, Appoints Kathleen LaPorte as Chief Business Officer

Wed, 08/06/2014 - 15:15
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Nodality, Inc., an innovative biotechnology company advancing discovery, development and use of transformative therapies across broad therapeutic categories, with a focus on immunology an...
Biopharmaceuticals, Personnel
Nodality, Single Cell Network Profiling

Tufts Medical Center and ATON Partners Announce Formation of CereVasc, LLC

Wed, 08/06/2014 - 12:23
Development Stage Company to Focus on Breakthrough Treatments of Neurological Diseases BOSTON, Aug. 6, 2014 -- (Healthcare Sales & Marketing Network) -- Tufts Medical Center and ATON Partners, LLC today announced the formation of CereVasc, LLC, a rese...
Devices, Neurosurgery
ATON Partners, CereVasc , hydrocephalus

Synta Names Anne Whitaker Chief Executive Officer

Wed, 08/06/2014 - 12:16
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Synta Pharmaceuticals Corp. (SNTA) today announced that Anne Whitaker will join the Company as President, Chief Executive Officer and a member of the Company’s Board of Directors effective September...
Biopharmaceuticals, Personnel
Synta Pharmaceuticals

Akebia Therapeutics Announces Expansion of Management Team

Wed, 08/06/2014 - 12:13
Key additions will help drive strategic growth and advance lead clinical programs CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Akebia Therapeutics, Inc. (AKBA), a biopharmaceutical company focused on harnessing the potential of hypoxia-indu...
Biopharmaceuticals, Personnel
Akebia Therapeutics, hypoxia-inducible factor

FDA Approves the SynCardia Total Artificial Heart With SynHall Valves

Tue, 08/05/2014 - 17:01
SynCardia Systems, Inc., now controls last key component in heart manufacturing TUCSON, Ariz., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- SynCardia Systems, Inc. received approval July 2, 2014 from the United States Federal Drug Administ...
Devices, Cardiology, FDA
SynCardia Systems, Total Artificial Heart, SynHall valve

IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery

Tue, 08/05/2014 - 16:57
100% Local (Resection Cavity) Freedom From Progression With 19.3 Month Median Follow-Up RICHLAND, WA--(Healthcare Sales & Marketing Network) - IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radi...
Devices, Neurosurgery, Oncology
IsoRay, Cesium-131, brachytherapy, brain cancer, radiotherapy

EDAP Comments on FDA Panel Vote

Tue, 08/05/2014 - 16:52
Responds to Gastroenterology and Urology Devices Panel Vote on Ablatherm-HIFU for Treatment of Prostate Cancer LYON, France, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today...
Devices, Oncology, FDA
EDAP TMS, Ablatherm, high-intensity focused ultrasound, prostate cancer

CardioMEMS Heart Failure Monitoring System Receives Approval from CMS for New Technology Add-On Payment

Tue, 08/05/2014 - 16:48
St. Jude Medical’s CardioMEMS HF System demonstrates our commitment to delivering high-quality, innovative solutions that reduce health care costs and improve outcomes for patients ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medic...
Devices, Cardiology, Reimbursement
St. Jude Medical, CardioMEMS, pulmonary artery pressure

Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors

Tue, 08/05/2014 - 16:44
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced today that it has appointed Jean-Pierre Sommadossi, PhD, to the company’s Board of Dire...
Biopharmaceuticals, Neurology, Personnel
Alzheon, ALZ-801, Alzheimer’s disease

MELA Sciences Names Michael R. Stewart to Board of Directors

Tue, 08/05/2014 - 16:41
Stewart Brings to MELA a Wealth of Dermatological Medical Device Expertise Across All Aspects of the Business IRVINGTON, N.Y., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- MELA Sciences, Inc. (MELA), developer of the MelaFind(R) system, an ...
Devices, Diagnostics, Oncology, Dermatology, Personnel
MELA Sciences, MelaFind, melanoma

Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market

Tue, 08/05/2014 - 12:25
QUÉBEC CITY, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) - Aeterna Zentaris Inc. (AEZS) (TSX: AEZ) (the "Company") today announced a strategic co-promotion services agreement with ASCEND Therapeutics® US, LLC, ("ASCEND...
Biopharmaceuticals, Distribution
Aeterna Zentaris, ASCEND Therapeutics, EstroGel, Macrilen

Boston Therapeutics Expands Medical Advisory Board

Tue, 08/05/2014 - 12:20
Noted Diabetes Experts Meng H Tan, M.D., Philip Raskin, M.D., and Charles M. Clark, Jr., M.D. to Serve as Medical Advisory Board Members MANCHESTER, NH--(Healthcare Sales & Marketing Network)) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Ther...
Biopharmaceuticals, Personnel
Boston Therapeutics

TesoRx Closes $10M in Funding, Secures Key Patent and Hires Renowned Urologist as Chief Medical Officer

Tue, 08/05/2014 - 12:15
MENLO PARK, Calif., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- TesoRx Pharma, LLC., a specialty pharmaceutical company focused on rapidly developing and commercializing products in specialty and niche markets, announced today that it has cl...
Biopharmaceuticals, Personnel, Venture Capital
TesoRx Pharma

Caris Molecular Intelligence(TM) Identifies Key Biomarkers of Clinical Benefit and Resistance to Chemotherapy through Multi-Technology Tumor Profiling

Tue, 08/05/2014 - 12:11
Peer-Reviewed Case Study from Fox Chase Cancer Center Demonstrates Value of Company's Unique Approach to Precision Medicine to Uncover Critical Treatment Insights IRVING, Texas, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- Caris Life Scien...
Diagnostics, Oncology
Caris Life Sciences, Molecular Intelligence, tumor profiling

Akers Appoints New Vice President of International Sales and Marketing to Build International Business

Tue, 08/05/2014 - 12:04
THOROFARE, N.J., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- Akers Biosciences, Inc. (AKER) (AKR.L) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and testing products, announ...
Diagnostics, Personnel
Akers Biosciences

Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF)

Tue, 08/05/2014 - 12:01
SAN DIEGO, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to Genoa fo...
Biopharmaceuticals, FDA
Genoa Pharmaceuticals, pirfenidone, Esbriet, Idiopathic Pulmonary Fibrosis

RestorGenex Appoints Mark Weinberg, MD, MBA Senior Vice President of Clinical Development

Mon, 08/04/2014 - 10:54
CHICAGO--(Healthcare Sales & Marketing Network)-RestorGenex Corporation (RESX), a specialty biopharmaceutical company initially focused on developing products for dermatology, ophthalmology and women’s health, announced today the appointment of Mark Weinbe...
Biopharmaceuticals, Personnel
RestorGenex

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong